Has David Armstrong, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,236,458 in general payments to David Armstrong, MD across 94 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean David Armstrong, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about David Armstrong, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

David Armstrong, MD

Colon & Rectal Surgery · Lawrenceville, GANPI 1720046089

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $1,234,703 of the $1,236,458 with a category attached, or 99.9%. 24 manufacturers reported payments, led by Cook Incorporated at 54.8% of the total. Reporting peaked in 2024 at $251,702 and has fallen 63.0% since, to $93,145 in 2025. Among colon & rectal surgery clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,236,458in general payments, 2019–2025

Across 94 payments — averaging $13,154 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Cook Incorporated$678K
RTI Surgical, Inc$322K
Cook Biotech Incorporated$207K
Wilson Cook Medical Incorporated$29K
Convatec Inc.$530
Medtronic$312
plus $913 from 18 others

$11,392in research payments, 2019–2025

Across 2 payments — averaging $5696.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Cook Biotech Incorporated$11K

What the payments were for

Royalty or licence$1,234,703100%
Consulting fees$5300%
Food & beverage$1,1250%
Education$1000%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Cook Incorporated	31	$677,680
RTI Surgical, Inc	11	$321,821
Cook Biotech Incorporated	6	$206,531
Wilson Cook Medical Incorporated	4	$28,671
Convatec Inc.	1	$530
Medtronic	6	$312
Johnson & Johnson(2 entities)	5	$189
Myriad Genetic Laboratories, Inc.	2	$143
Merck	6	$121
Davol Inc.	2	$73
Axonics, Inc.	2	$54
La Jolla Pharmaceutical Company	3	$47
Regeneron Healthcare Solutions, Inc.	2	$46
Dilon Technologies, Inc.	2	$34
Baxter Healthcare	2	$33
Sirtex Medical Inc	1	$28
CSL Behring	1	$23
Daiichi Sankyo Inc.	1	$22
Hologic Sales And Service, LLC	1	$20
AstraZeneca	1	$19
Innovation Technologies Inc	1	$18
Integra Lifesciences Corporation	1	$17
Intuitive Surgical	1	$13
Cook Medical LLC	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

BIODESIGN$528,352
Saeed$26,392
Cook$24,685
AQUACEL AG$530
PreciseTumor$119
INTERSTIM$114

How this compares

$1,236,458 in reported general payments places this provider in the 95th percentile of 66 colon & rectal surgery providers in Georgia.

See all colon & rectal surgery providers in Georgia →

Medicare billing

Part B allowed, 2024

$126,859

Medicare patients

218

Services billed

462

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine	25	$887
Metronidazole	104	$279
Neomycin Sulfate	28	$103

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Lawrenceville

Jeffrey CohenMarietta$663K
Erin King-MullinsMacon$119K
Jay SinghRoswell$102K
Jason PetrofskiCumming$74K
Dennis ChoatFayetteville$65K
Seth RosenJohns Creek$42K
Patrick SullivanAtlanta$41K
Jose AycinenaGainesville$33K
Fia YiAthens$32K
Osama AtallahMacon$23K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →